Literature DB >> 1467139

Plasma morphine-3-glucuronide, morphine-6-glucuronide and morphine concentrations in patients receiving long-term epidural morphine.

J J Schneider1, P J Ravenscroft, J D Cavenagh, A M Brown, J P Bradley.   

Abstract

Plasma morphine concentrations were measured in five cancer patients receiving long-term epidural morphine administration. Peak concentrations were observed within 1 h of dosage and concentrations then declined biexponentially. Plasma morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) concentrations were measured in two patients and plasma M3G concentrations were observed to be much higher than plasma M6G and morphine concentrations. Peak plasma M6G concentrations occurred within 1.0 h of dosing and plasma M6G concentrations then remained higher than plasma morphine concentrations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1467139      PMCID: PMC1381473          DOI: 10.1111/j.1365-2125.1992.tb05651.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Determination of morphine in plasma by high-performance liquid chromatography with fluorescence detection.

Authors:  J J Schneider; P J Ravenscroft
Journal:  J Chromatogr       Date:  1989-12-29

2.  Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain.

Authors:  M B Max; C E Inturrisi; R F Kaiko; P Y Grabinski; C H Li; K M Foley
Journal:  Clin Pharmacol Ther       Date:  1985-12       Impact factor: 6.875

3.  An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites.

Authors:  S P Joel; R J Osborne; M L Slevin
Journal:  J Chromatogr       Date:  1988-09-09

4.  Analgesic effect of morphine glucuronides.

Authors:  K Shimomura; O Kamata; S Ueki; S Ida; K Oguri; H Yoshimura; H Tsukamoto
Journal:  Tohoku J Exp Med       Date:  1971-09       Impact factor: 1.848

5.  Analgesic activity of morphine-6-glucuronide.

Authors:  R Osborne; S Joel; D Trew; M Slevin
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

6.  Morphine-3-glucuronide--a potent antagonist of morphine analgesia.

Authors:  M T Smith; J A Watt; T Cramond
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

7.  Serum levels following epidural administration of morphine and correlation with relief of postsurgical pain.

Authors:  S J Weddel; R R Ritter
Journal:  Anesthesiology       Date:  1981-03       Impact factor: 7.892

8.  Steady-state kinetics and analgesic effect of oral morphine in cancer patients.

Authors:  J Säwe; B Dahlström; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  8 in total
  2 in total

1.  Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study.

Authors:  M J Barjavel; J M Scherrmann; H N Bhargava
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 2.  Opioids Preconditioning Upon Renal Function and Ischemia-Reperfusion Injury: A Narrative Review.

Authors:  Julio Palomino; Raquel Echavarria; Adriana Franco-Acevedo; Bibiana Moreno-Carranza; Zesergio Melo
Journal:  Medicina (Kaunas)       Date:  2019-08-23       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.